Healius Limited Stock: price and insider trades · Australia

Headquartered in Sydney, Australia, Healius Limited belongs to the Health Care sector. Filings by its managers are published through ASX. Between 18 October 2025 and 18 October 2026, 14 insiders published 42 filings.

The flow runs one way only: 2 insiders bought (6 purchases totalling €12k) and nobody sold on the market. No amount is published for 5 filings, which the totals therefore leave out. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Katherine Ostin filed the largest purchase, €12k, on 22 April 2026, which represents 0.0059% of the company's market value. Those buying include 2 senior executives.

The most recent open-market purchase was published on 27 August 2026, 51 days ago. The median gap between a trade and its publication by ASX is 4 days. This delay matters because a trade only becomes useful information once it is public.

Compared with its exchange (2,222 companies, median 3 filings), a count of 42 filings is above the norm. Looking back to 2026, when coverage begins, insiders filed 6 purchases and no sales.

Other companies in the same sector with recent insider buying flagged by our signals: Anixa Biosciences Inc and Vivos Inc. These figures are compiled from regulatory filings published by ASX. They describe what insiders did and are not a recommendation.